Neve Llan, Israel-based Medical imaging company Nanox (NASDAQ: NNOX) is to acquire Zebra Medical Vision, a Kibbutz Shefayim, Israel-based deep-learning medical imaging analytics company, for up to $200m.
USD100m will be paid upfront and up to additional USD100m, subject to certain deductions, will be paid upon achievement of certain milestones. As a result of the acquisition, Nanox will leverage Zebra-Med’s team, AI technology and cloud capabilities, and regulatory framework to expand its mission of diagnosing populations at scale with its AI-based solutions, enabling IDNs and commercial payers to detect and treat patients at risk for chronic conditions while accurately adjusting their covered population risk.
Led by Zohar Elhanani, CEO, Zebra Medical Vision provides an imaging analytics platform that allows healthcare institutions to identify patients at risk of disease and offer improved preventative treatment pathways to advance patient care. The company has raised $52m in funding to date by Khosla Ventures, Marc Benioff, Intermountain Investment Fund, OurCrowd Qure, Aurum, aMoon, Nvidia, J&J and Dolby Ventures. Zebra-Med leads the way in AI FDA cleared products, and is installed in hospitals globally, from Australia to India, Europe to the U.S, and the LATAM region.
Led by Ran Poliakine, Chairman and Chief Executive Officer, Nanox is an Israeli corporation developing a commercial-grade digital X-ray source designed to be used in real-world medical imaging applications.